Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (10)
  • Open Access

    ARTICLE

    Transperineal prostate biopsy without routine antibiotics demonstrates decreased infection risk

    Benjamin J. Lichtbroun1,2,*, Mann Patel2, Alexis Consalvo2, Labeeqa Khizir2, Munisa Said2, Austin Chien2, Kevin Chua1,2, John Pfail1,2, Rachel Passarelli1,2, Vignesh T. Packiam1, David Golombos1, Sammy Elsamra2, Thomas L. Jang1, Arnav Srivastava1,3, Saum Ghodoussipour1

    Canadian Journal of Urology, Vol.32, No.1, pp. 55-62, 2025, DOI:10.32604/cju.2025.064701 - 20 March 2025

    Abstract Introduction: Infections are the most feared complication of transrectal prostate biopsies, along with growing concerns of antibiotic resistance. Our institution transitioned to a transperineal approach without use of perioperative antibiotics or bowel preparations. We aimed to compare the safety outcomes associated with transperineal and transrectal prostate biopsy techniques. Materials and Methods: A retrospective analysis of patients who underwent transrectal and transperineal prostate biopsies at our institution from 2019–2022 was performed. Results: We identified 319 patients—174 transrectal and 145 transperineal. 8 patients who had transperineal biopsy (5.5%) received peri-operative antibiotics, compared to 100% with transrectal biopsy. 35.86%… More >

  • Open Access

    REVIEW

    The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative review

    MICHELE MAFFEZZOLI1,2,#, GIULIA CLAIRE GIUDICE1,2,#,*, GIACOMO IOVANE1,2, MARTINA MANINI1,2, ELENA RAPACCHI1, GIUSEPPE CARUSO1, NICOLA SIMONI3, STEFANIA FERRETTI4, STEFANO PULIATTI4, DAVIDE CAMPOBASSO5, SEBASTIANO BUTI1,2

    Oncology Research, Vol.33, No.4, pp. 741-757, 2025, DOI:10.32604/or.2024.057278 - 19 March 2025

    Abstract Background: immune checkpoint inhibitors (ICIs) have revolutionized the treatment of metastatic urothelial carcinoma (mUC), significantly improving survival outcomes. However, a subset of patients do not respond to ICIs, prompting research into potential predictive factors. Commonly prescribed medications such as corticosteroids, proton-pump inhibitors (PPIs), antibiotics (Abs), antihypertensives, and analgesics may influence ICI effectiveness. Methods: we conducted a literature search on PubMed to investigate the impact of concomitant medications on the outcomes of patients with mUC, treated with ICIs. We selected the most relevant studies and performed a narrative review. Results: corticosteroids, PPIs and Abs have been associated More >

  • Open Access

    ARTICLE

    Antibiotic resistance in patients undergoing serial prostate biopsies: risk factors and impact on clinical outcomes

    Alex J. Xu1, Sameer Thakker2, Vyom Sawhney2, Rozalba Gogaj1, Fjolla Vokshi1, James S. Wysock1

    Canadian Journal of Urology, Vol.31, No.1, pp. 11767-11774, 2024

    Abstract Introduction: We evaluate the rate of developing ciprofloxacin resistance in patients undergoing repeat prostate biopsies (PBx), associated risk factors, and impact on complications.
    Materials and methods: We retrospectively evaluated pre-procedural rectal culture (RCx) data in men undergoing PBx from 1/1/2016 to 1/15/2021. Univariate and multivariate logistic regression were utilized to identify risk factors associated with development of antibiotic resistance. Complication rates were compared between ciprofloxacin-sensitive and ciprofloxacin resistant patients.
    Results: A total of 743 men underwent initial RCx. Initial RCx detected ciprofloxacin resistance in 22% of patients. A history of diabetes (p = 0.01), > 2 prior prostate… More >

  • Open Access

    ARTICLE

    Less is more: single dose versus extended antibiotic prophylaxis for transperineal prostate biopsy

    Maxwell Sandberg1, Wyatt Whitman1, Janmejay Hingu1, Parth Thakker1, Anita Rong2, Caleb Bercu2, Jacob Greenberg3, Ronald Davis III1, Ashok Hemal1, Matvey Tsivian1

    Canadian Journal of Urology, Vol.30, No.4, pp. 11599-11604, 2023

    Abstract Introduction: There is an ongoing debate as to the appropriate regimen of antibiotic prophylaxis with transperineal (TP) biopsy. The objective of this study was to report the rate of infection following TP biopsy at a high-volume institution and assess the impact of single dose antibiotics at the time of biopsy versus outpatient antibiotics in preventing postprocedural infections.
    Materials and methods: Records of men undergoing TP prostate biopsy from 2012 to 2022 were reviewed. Patients were divided into two groups, those who received single dose intravenous (IV) antibiotics at the time of biopsy (n = 440) and those… More >

  • Open Access

    ARTICLE

    Deoxynortryptoquivaline: A unique antiprostate cancer agent

    YOHKO YAMAZAKI1,*, MANABU KAWADA2, ISAO MOMOSE1

    Oncology Research, Vol.31, No.6, pp. 845-853, 2023, DOI:10.32604/or.2023.030266 - 15 September 2023

    Abstract The androgen receptor (AR) is a critical target in all the clinical stages of prostate cancer. To identify a new AR inhibitor, we constructed a new screening system using the androgen-dependent growth of prostate cancer cell lines as a screening indicator. We screened 50,000 culture broths of microorganisms using this screening system and found that the fermentation broth produced by a fungus inhibited androgen-dependent growth of human prostate cancer LNCaP cells without cytotoxicity. Purification of this culture medium was performed, and this resulted in deoxynortryptoquivaline (DNT) being identified as a novel inhibitor of AR function. More > Graphic Abstract

    Deoxynortryptoquivaline: A unique antiprostate cancer agent

  • Open Access

    ARTICLE

    Evaluation of Beta-Lactam Antibiotics on the Regeneration of Peanut Plants and Their Inhibitory Effect on Agrobacterium Growth

    Abraham Lamboro1,3,*, Songnan Yang1, Xueying Li1, Dan Yao2, Jun Zhang1,*

    Phyton-International Journal of Experimental Botany, Vol.92, No.9, pp. 2489-2501, 2023, DOI:10.32604/phyton.2023.029492 - 28 July 2023

    Abstract The effect of beta-lactam antibiotics on shoot induction and plantlet regeneration from cotyledonary nodes was tested using two peanut cultivars. The culture media contained 4 mg/L 6-benzylaminopurine (BAP) as the main growth regulator. Various concentrations (100–600 mg/L) of cefotaxime, carbenicillin, and timentin were applied in the culture media. In all the tested media, there were no significant differences in the shoot induction as compared to the control. However, little phytotoxic effect was observed at higher concentrations of these antibiotics in the shoot elongation media. Under shoot elongation medium, shoots turned brownish and partly died at… More >

  • Open Access

    ARTICLE

    Secondary antiviral metabolites from fungi with special reference to coronaviruses

    MOHAMED SALEM1,2, MOHAMMAD EL-METWALLY3, WESAMELDIN SABER4,*, SALLY NEGM5,6, ATTALLA EL-KOTT7.8, YASSER MAZROUA9,10, ABEER MAKHLOUF11, MAHMOUD MOUSTAFA7,12

    BIOCELL, Vol.46, No.8, pp. 1979-1988, 2022, DOI:10.32604/biocell.2022.019301 - 22 April 2022

    Abstract Profound inspection of the life forms on the earth teaches how to be the complexity of interrelationships among the various systems. Because of the emergence of novel viruses all the time and the inadequate of vaccines and antivirals, viral contagions are amongst the most causative diseases affecting people worldwide. Fungi exemplify a massive source of bioactive molecules as, many fungal secondary metabolities like Oxoglyantrypine, Carneic acid F, Scedapin C, Asteltoxin E, Phomanolide, Norquinadoline A and Quinadoline B have antiviral activity. This review deals with how secondary metabolites of fungi can help in the war against More >

  • Open Access

    ARTICLE

    Evaluation of Ocimum basilicum L. with Different Concentrations of K+ as an Inhibitor of Pathogenic Bacterial Strains

    Mercedes Georgina Ramírez-Aragón1, Victoria Jared Borroel-García1, Ramón Valenzuela-Soto1, Ricardo David Valdez-Cepeda2, Francisco Javier Wong-Corral3, José Luis García-Hernández4,*

    Phyton-International Journal of Experimental Botany, Vol.90, No.2, pp. 533-541, 2021, DOI:10.32604/phyton.2021.013166 - 07 February 2021

    Abstract The extraction of bioactive compounds has become one of the most interesting areas of modern chemistry. For therapeutic reasons, it´s important to obtain antimicrobial agents from natural origin. The objective of the present study was to determine the inhibitory effect of ethanolic extract of basil (Ocimum basilicum L. var. Red Rubin) subjected to different concentrations of potassium (K+) on the activity of three bacterial strains that are pathogens in humans. Susceptibility was evaluated by inhibition surface and these results were compared to two antibiotics: Gentamicin (GE) and Ciprofloxacin (CPF) for their efficacy against each bacterial strain. Analyzed More >

  • Open Access

    COMMENTARY

    Do antibiotics cause AUS infections?

    Jack M. Zuckerman

    Canadian Journal of Urology, Vol.27, No.6, pp. 10443-10443, 2020

    Abstract This article has no abstract. More >

  • Open Access

    ARTICLE

    Are postoperative antibiotics necessary after artificial urinary sphincter insertion?

    Benjamin M. Dropkin1, Jeremiah D. Dallmer2, Leah P. Chisholm2, Niels V. Johnsen1, Roger R. Dmochowski1, Douglas F. Milam1, Melissa R. Kaufman1

    Canadian Journal of Urology, Vol.27, No.6, pp. 10437-10442, 2020

    Abstract Introduction: We sought to explore whether patients discharged without antibiotics after artificial urinary sphincter (AUS) insertion were more likely to require device explantation for infection or erosion compared to patients discharged with antibiotics at our institution and compared to patients in other large, contemporary series.
    Materials and methods: AUS insertions performed at our institution between 2013 and 2017 were retrospectively reviewed to determine demographics, comorbidities, and perioperative and medium-term outcomes. Patients were grouped based on 1) known risk factors for infectious complications or erosion and 2) postoperative antibiotic prescription status. Patients were placed in Group 1 if… More >

Displaying 1-10 on page 1 of 10. Per Page